2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$5.49-$0.01 (-0.27%)
Price as of Aug 21, 2026 7:48 PM EDT- $547.5MMarket Cap
- -59.22%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$5.49-$0.01 (-0.27%)
SPRY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.50 | ||
Change | $0.00 (0.00%) | ||
Open | $5.52 | ||
High | $5.60 | ||
Low | $5.46 | ||
Previous Close | $5.50 | ||
Volume | 1,267,922 | ||
30-Day Average Volume | 2,290,677 | ||
1-Week Change | -2.57% | ||
1-Month Change | -13.44% | ||
1-Year Change | -59.22% | ||
3-Year Change | -21.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 99.4M | ||
Total Assets | $249.5M | ||
Market Cap | $547.5M | ||
Enterprise Value | $636.0M | ||
Period: QTR TTM FY | |||
Revenue | $26.2M | ||
Net Income | -$62.3M | ||
Free Cash Flow | -$60.9M | ||
EBIT | -$62.3M | ||
EBITDA | -$61.9M | ||
Net Working Capital | $150.6M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 44 | ||
P/E | -9 | ||
PEG | 3 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue